Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ELF1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
mRNA | TUBB1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SPCS1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | TAGAP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
mRNA | ETFB | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | COMTD1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | AC242988.1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ZP2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | TAF12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | EEF1A2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |